Altimmune, Inc. (ALT) › Total AssetsAltimmune, Inc. (ALT) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $27.20M2011: $22.80M2012: $22.74M2013: $17.14M2014: $21.98M2015: $19.86M2016: $38.40M2017: $63.03M2018: $54.75M2019: $54.06M2020: $245.12M2021: $218.87M2022: $206.93M2023: $210.64M2024: $139.31M2025: $279.93M$279.93M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$279.93M+100.9%2024$139.31M-33.9%2023$210.64M+1.8%2022$206.93M-5.5%2021$218.87M-10.7%2020$245.12M+353.4%2019$54.06M-1.3%2018$54.75M-13.1%2017$63.03M+64.1%2016$38.40M+93.3%2015$19.86M-9.6%2014$21.98M+28.2%2013$17.14M-24.6%2012$22.74M-0.3%2011$22.80M-16.2%2010$27.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share